Target intelligence / Profile preview

MexAB-OprM efflux pump (MexAB-OprM)

Target
MexAB-OprM
Molecular classification
Transporter, Efflux pump, Resistance–Nodulation–Division (RND) family transporter, Tripartite efflux system
01

Overview

The MexAB-OprM efflux pump is a major tripartite multidrug efflux complex in Pseudomonas aeruginosa, composed of three main proteins: MexA (a membrane fusion protein), MexB (a resistance–nodulation–division [RND] transporter in the inner membrane), and OprM (an outer membrane factor channel)[1][6][7]. These subunits span the inner and outer bacterial membranes and the periplasmic space, forming a conduit that actively transports a wide range of antibiotics and toxic compounds from the cytoplasm directly to the extracellular environment, bypassing the periplasm[1][4][7]. This efflux mechanism is powered by the proton motive force, enabling P. aeruginosa to resist treatment with various antibiotics, and is a key contributor to the organism’s notable multidrug resistance. The operon encoding these components is tightly regulated but can be upregulated in clinical settings, further complicating treatment of infections caused by this opportunistic pathogen[3][8].

Other names
MexAB-OprM multidrug efflux pumpMexAB-OprM pumpMexA–MexB–OprM complexMexA, MexB, OprM (refers to the subunits)
02

Mechanism of action

Efflux of structurally diverse drugs and toxic compounds from the bacterial cell, thereby reducing intracellular concentrations and conferring resistance[6][8][1].\nProton motive force-driven active export, using energy across the inner membrane[6][1].

03

Biological functions

Antibiotic effluxMultidrug resistanceDrug extrusionToxin effluxRegulation of quorum sensing and bacterial virulence
04

Disease associations

InfectionMultidrug-resistant bacterial infection (notably in Pseudomonas aeruginosa)Hospital-acquired infection
05

Safety considerations

Not directly applicable to human safety, but the therapeutic challenge is that MexAB-OprM mediates high-level resistance in P. aeruginosa, severely limiting antibiotic efficacy and complicating infection management[8].Overexpression can occur in clinical isolates, leading to multidrug-resistant and difficult-to-treat infections[3].
06

Interacting drugs

β-lactam antibiotics

12 more in the full profile.

07

Biomarkers

Overexpression of mexAB-oprM operon as a marker for multidrug resistance in P. aeruginosa[3].Mutations in regulatory genes (e.g., mexR) as a marker for increased MexAB-OprM activity[5].

Beyond the preview

Go deeper on MexAB-OprM efflux pump (MexAB-OprM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MexAB-OprM efflux pump (MexAB-OprM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call